ACCELERATING SCIENTIFIC DISCOVERY with CASE STUDY COMPANY OVERVIEW How one pharma company has advanced their drug discovery & development process A leading global biologics research and development company embarked on an ambitious plan to accelerate the discovery of new therapeutic targets through population genetics on a cohort of over one million genomes. Their drug discovery and development efforts focus on three core therapeutic areas: Oncology Respiratory, Inflammation and Autoimmune Cardiovascular and Metabolic Disease As the company expanded their portfolio of biologic therapeutic agents, and incorporated translational and precision approaches to their R&D pipeline, they faced a deluge of data. The R&D teams had access to massive volumes of combined clinic

Join for free to read